PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.\', \'Department of Cardiology, Hospital Clínico Universitario Virgen de La Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.\', \'Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.\', \'TriNetX LLC., Cambridge, MA, USA.\', \'TriNetX LLC., London, UK.\', \'Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK. gregory.lip@liverpool.ac.uk.\', \'Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. gregory.lip@liverpool.ac.uk.\', \'Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. gregory.lip@liverpool.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12933-021-01368-6
?:doi
?:hasPublicationType
?:journal
  • Cardiovascular diabetology
is ?:pmid of
?:pmid
?:pmid
  • 34481513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.157
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all